New York, New York, United States New Mountain Capital appeared to be the VC, which was created in 2000. The leading representative office of defined VC is situated in the New York. The fund was located in North America if to be more exact in United States.
The standard case for the fund is to invest in rounds with 1-2 partakers. Despite the New Mountain Capital, startups are often financed by Venrock, Summit Partners, Noro-Moseley Partners. The meaningful sponsors for the fund in investment in the same round are Venrock, ARCH Venture Partners, Vestar Capital Partners. In the next rounds fund is usually obtained by Vestar Capital Partners, Frazier Healthcare Partners.
Comparing to the other companies, this New Mountain Capital performs on 2 percentage points more the average number of lead investments. The fund is constantly included in less than 2 investment rounds annually. The real fund results show that this VC is 55 percentage points more often commits exit comparing to other companies. The higher amount of exits for fund were in 2015. The usual things for fund are deals in the range of more than 100 millions dollars. The high activity for fund was in 2017. Despite it in 2019 the fund had an activity.
Among the most popular portfolio startups of the fund, we may highlight Ikaria, IRI, Stroz Friedberg. Among the most successful fund investment fields, there are Biotechnology, Medical. The fund has specific favorite in a number of founders of portfolio startups. Besides, a startup requires to be at the age of 11-15 years to receive the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States.
The current fund was established by Steven Klinsky. Besides them, we counted 39 critical employees of this fund in our database.
Related Funds
| Fund Name | Location |
| 1823 Ventures | Central, Central Region, Singapore |
| AMS INDUSTRIES | France, Ile-de-France, Paris |
| Archer Investment Management | North Carolina, Raleigh, United States |
| Central Illinois Angels | Illinois, Peoria, United States |
| Centre for Drug Design & Discovery (CD3) | Belgium, Flemish Brabant, Vlaams-Brabant |
| Ipanema Technologies | Courceboeufs, France, Pays de la Loire |
| Kepventure Pte Ltd | - |
| Less Plastics | Canada, Gatineau, Quebec |
| Long Venture Partners | California, San Francisco, United States |
| prominent venture capital | - |
| Qingyuan Xinlin Venture Investment Management | China, Jiangsu, Suzhou |
| RPS Ventures | California, Palo Alto, United States |
| Seneca Partners | Birmingham, Michigan, United States |
| Shubei Investment | China, Hangzhou, Zhejiang |
| Summit Capital | Seattle, United States, Washington |
| The Future Fund | England, London, United Kingdom |
| Victorian Clean Technology Fund | - |
| Wittington Portland Murdoch | - |
| Zhehua Investment | China, Jiaxing, Zhejiang |
Discover 5 more decision makers Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Bellerophon Therapeutics | $80M | 26 Dec 2013 | New Jersey, United States | ||
Ikaria | $280M | 01 Mar 2007 | Hampton, New Jersey, United States |
– Bounteous, a Chicago, IL-based insights-driven digital experience consultancy, received an investment from New Mountain Capital.
– The amount of the deal was not disclosed.
– The company intends to use the funds to make strategic investments in talent, new service offerings, and the Co-Innovation enablement methods that it uses to drive clients’ digital transformation programs.
– HomeX from Chicago provides a home services platform for homeowners and service providers.
– The company closed $90m in funding.
– The round was led by New Mountain Capital.
– The company intends to use the funds to expand its services across North America.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Bellerophon Therapeutics | $80M | 26 Dec 2013 | New Jersey, United States | ||
Ikaria | $280M | 01 Mar 2007 | Hampton, New Jersey, United States |
